Evidence map›Paper›PMID 26668261›Full record

ArticleJournal of bacteriology2015

Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness.

Tanya L Johnson, Ursula Waack, Sara Smith, Harry Mobley, Maria Sandkvist

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Functional potential of gut microbiota inFrontiers in microbiology · 2026
    Article
  5. Article
  6. High Prevalence of Virulence andPathogens (Basel, Switzerland) · 2025
    Article
  7. Circulation research · 2025
    Article
  8. Prevalence and Antibiogram Pattern ofAntibiotics (Basel, Switzerland) · 2025
    Article
  9. A decade of genomic and phenotypic adaptation of carbapenem-resistantFrontiers in cellular and infection microbiology · 2025
    Article
  10. The intricacies ofFrontiers in microbiology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Treatment and Management ofInfection and drug resistance · 2024
    Review
  18. Review
  19. Uncovering the Secretion Systems ofAntibiotics (Basel, Switzerland) · 2023
    Review
  20. Deciphering the virulence factors, regulation, and immune response toFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tanya L JohnsonDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA Department of Chemistry, Eastern Michigan University, Ypsilanti, Michigan, USA.
Ursula WaackDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Sara SmithDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Harry MobleyDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Maria SandkvistDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA mariasan@umich.edu.
University of Michigan–Ann Arbor · US

Funding

Organization and Function of a Type II Secretion ComplexR01AI049294 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDKVIST, MARIA B · 2002 to 2012
$2.9M
Genome-wide identification of virulence genes in Acinetobacter baumannii in vivoR21AI107184 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOBLEY, HARRY L. · 2014 to 2015
$428k
Organization and function of a type II secretion complexR56AI049294 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDKVIST, MARIA B · 2015 to 2015
$393k
NIAID NIH HHS AI107184NIAID NIH HHS AI49294NIAID NIH HHS R01 AI049294NIAID NIH HHS R21 AI107184NIAID NIH HHS R56 AI049294
6 · The paper itself

Abstract

unlabelledGram-negative bacteria express a number of sophisticated secretion systems to transport virulence factors across the cell envelope, including the type II secretion (T2S) system. Genes for the T2S components GspC through GspN and PilD are conserved among isolates of Acinetobacter baumannii, an increasingly common nosocomial pathogen that is developing multidrug resistance at an alarming rate. In contrast to most species, however, the T2S genes are dispersed throughout the genome rather than linked into one or two operons. Despite this unique genetic organization, we show here that the A. baumannii T2S system is functional. Deletion of gspD or gspE in A. baumannii ATCC 17978 results in loss of secretion of LipA, a lipase that breaks down long-chain fatty acids. Due to a lack of extracellular lipase, the gspD mutant, the gspE mutant, and a lipA deletion strain are incapable of growth on long-chain fatty acids as a sole source of carbon, while their growth characteristics are indistinguishable from those of the wild-type strain in nutrient-rich broth. Genetic inactivation of the T2S system and its substrate, LipA, also has a negative impact on in vivo fitness in a neutropenic murine model for bacteremia. Both the gspD and lipA mutants are outcompeted by the wild-type strain as judged by their reduced numbers in spleen and liver following intravenous coinoculation. Collectively, our findings suggest that the T2S system plays a hitherto-unrecognized role in in vivo survival of A. baumannii by transporting a lipase that may contribute to fatty acid metabolism. IMPORTANCE: Infections by multidrug-resistant Acinetobacter baumannii are a growing health concern worldwide, underscoring the need for a better understanding of the molecular mechanisms by which this pathogen causes disease. In this study, we demonstrated that A. baumannii expresses a functional type II secretion (T2S) system that is responsible for secretion of LipA, an extracellular lipase required for utilization of exogenously added lipids. The T2S system and the secreted lipase support in vivo colonization and thus contribute to the pathogenic potential of A. baumannii.

Indexed as

Lipid MetabolismAcinetobacter baumanniiAcinetobacter InfectionsAmino Acid SequenceAnimalsBacterial ProteinsFemaleHumansMice, Inbred CBAMolecular Sequence DataSequence AlignmentType II Secretion SystemsBacterial ProteinsLipA protein, BacteriaType II Secretion Systems

Identifiers

PMID26668261
PMCPMC4751819
OpenAlexW2204081622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.